JP4140951B2 - 転写制御因子ｚｈｘ３ - Google Patents

転写制御因子ｚｈｘ３ Download PDF

Info

Publication number
JP4140951B2
JP4140951B2 JP2002366512A JP2002366512A JP4140951B2 JP 4140951 B2 JP4140951 B2 JP 4140951B2 JP 2002366512 A JP2002366512 A JP 2002366512A JP 2002366512 A JP2002366512 A JP 2002366512A JP 4140951 B2 JP4140951 B2 JP 4140951B2
Authority
JP
Japan
Prior art keywords
zhx3
zhx1
amino acid
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002366512A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004196700A (ja
JP2004196700A5 (enExample
Inventor
薫 宮本
一哉 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
National Institute of Japan Science and Technology Agency
Original Assignee
Japan Science and Technology Agency
National Institute of Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2002366512A priority Critical patent/JP4140951B2/ja
Application filed by Japan Science and Technology Agency, National Institute of Japan Science and Technology Agency filed Critical Japan Science and Technology Agency
Priority to CA2499354A priority patent/CA2499354C/en
Priority to PCT/JP2003/009164 priority patent/WO2004055051A1/ja
Priority to DE60331169T priority patent/DE60331169D1/de
Priority to US10/534,424 priority patent/US20070014790A1/en
Priority to EP03741487A priority patent/EP1574519B1/en
Publication of JP2004196700A publication Critical patent/JP2004196700A/ja
Publication of JP2004196700A5 publication Critical patent/JP2004196700A5/ja
Application granted granted Critical
Publication of JP4140951B2 publication Critical patent/JP4140951B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2002366512A 2002-12-18 2002-12-18 転写制御因子ｚｈｘ３ Expired - Fee Related JP4140951B2 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2002366512A JP4140951B2 (ja) 2002-12-18 2002-12-18 転写制御因子ｚｈｘ３
PCT/JP2003/009164 WO2004055051A1 (ja) 2002-12-18 2003-07-18 転写制御因子ｚｈｘ３
DE60331169T DE60331169D1 (de) 2002-12-18 2003-07-18 Transkriptionskontrollfaktor ZHX3
US10/534,424 US20070014790A1 (en) 2002-12-18 2003-07-18 Transcription control factor zhx3
CA2499354A CA2499354C (en) 2002-12-18 2003-07-18 Transcription control factor zhx3
EP03741487A EP1574519B1 (en) 2002-12-18 2003-07-18 Transcription control factor ZHX3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002366512A JP4140951B2 (ja) 2002-12-18 2002-12-18 転写制御因子ｚｈｘ３

Publications (3)

Publication Number Publication Date
JP2004196700A JP2004196700A (ja) 2004-07-15
JP2004196700A5 JP2004196700A5 (enExample) 2005-08-04
JP4140951B2 true JP4140951B2 (ja) 2008-08-27

Family

ID=32588313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002366512A Expired - Fee Related JP4140951B2 (ja) 2002-12-18 2002-12-18 転写制御因子ｚｈｘ３

Country Status (6)

Country Link
US (1) US20070014790A1 (enExample)
EP (1) EP1574519B1 (enExample)
JP (1) JP4140951B2 (enExample)
CA (1) CA2499354C (enExample)
DE (1) DE60331169D1 (enExample)
WO (1) WO2004055051A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102407411B1 (ko) * 2012-06-03 2022-06-10 가부시키가이샤 리코 분체 용기 및 화상 형성 장치
CN112309499A (zh) * 2020-11-09 2021-02-02 浙江大学 一种细菌pdif快速注释方法及装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1572987A4 (en) * 2000-02-03 2005-11-30 Nuvelo Inc NUCLEIC ACIDS AND POLYPEPTIDES
JP2003135075A (ja) * 2001-11-05 2003-05-13 Research Association For Biotechnology 新規な全長ｃＤＮＡ

Also Published As

Publication number Publication date
EP1574519B1 (en) 2010-01-27
JP2004196700A (ja) 2004-07-15
EP1574519A1 (en) 2005-09-14
US20070014790A1 (en) 2007-01-18
CA2499354C (en) 2010-01-26
DE60331169D1 (de) 2010-03-18
EP1574519A4 (en) 2006-04-12
WO2004055051A1 (ja) 2004-07-01
CA2499354A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
Kawata et al. Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor
Yamada et al. Analysis of zinc-fingers and homeoboxes (ZHX)-1-interacting proteins: molecular cloning and characterization of a member of the ZHX family, ZHX3
Svaren et al. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli
MacLellan et al. A novel Rb-and p300-binding protein inhibits transactivation by MyoD
Warner et al. Functional interaction between Smad, CREB binding protein, and p68 RNA helicase
Poleev et al. Distinct functional properties of three human paired‐box‐protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors
Sawa et al. YEAF1/RYBP and YAF-2 are functionally distinct members of a cofactor family for the YY1 and E4TF1/hGABP transcription factors
Seong et al. Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine protein serine/threonine kinase 38 (MPK38)
Staal et al. Molecular characterization of Celtix‐1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2
Sander et al. Identification of a novel SCAN box-related protein that interacts with MZF1B: the leucine-rich SCAN box mediates hetero-and homoprotein associations
Ito et al. SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex
JPH11313686A (ja) サイクリン依存性キナ―ゼの阻害剤の結合パ―トナ―、並びにそれらの阻害剤検索および疾病の診断または治療のための使用
KR20050085448A (ko) 조절성 징크 핑거 단백질
Rega et al. Identification of the full-length huntingtin-interacting protein p231HBP/HYPB as a DNA-binding factor
JP4140951B2 (ja) 転写制御因子ｚｈｘ３
Krum et al. Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity
Zhao et al. Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz‐1
Ogata-Kawata et al. BS69, a corepressor interacting with ZHX1, is a bifunctional transcription factor
EP1541685B1 (en) Factor participating in transcriptional regulation
EP1428891A1 (en) Novel gene nedl-1
WO2022261851A1 (zh) 植物jaz蛋白及衍生多肽在预防和治疗人与动物肿瘤中的应用
CN113135987A (zh) 一类来源于Caprin1的活性肽及其应用
JP4438951B2 (ja) Ａｋｔ２に結合する蛋白質
AU735512B2 (en) Modulators of BRAC1 activity
JP4419077B2 (ja) Ｃａｐ結合蛋白質

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050113

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050113

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080421

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080512

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080609

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080609

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110620

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120620

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120620

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130620

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees